A phase 2 trial evaluated the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in patients with urothelial non-muscle invasive bladder cancer.

The phase 2, single-arm INDIBLADE trial assessed induction ipilimumab plus nivolumab followed by CRT in patients with MIBC.

The National Health Fund (NHF) has expanded its NHFCard programme to include four additional chronic conditions and increased ...

Scottsdale leaders approved a program that will provide cancer screenings to local firefighters who are often exposed to ...

In TODAY.com's Never Have I Ever series, an expert describes what can happen when these muscles don't get enough attention.

I can’t get a good night’s sleep.”  After much cajoling, I got her to call her primary care provider who told her, as I had, ...

Watch two British men in suits and tuxedos take on the challenge of tasting 'tossed shredded fish maw,' also known as fish bladder. Their priceless reactions, humorous banter, and honest commentary ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a ...

NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without ...

CEO Richard Adcock used a presentation at the Citizens Life Sciences Conference to outline the company’s commercial progress ...